Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/17/20245:32PMBusiness WirePhilip Morris International: District of Columbia SubpoenaNYSE:PMPhilip Morris International Inc
06/17/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NGSNatural Gas Services Group Inc
06/17/20245:30PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:WUCTETRACS Whitney US Critical Technologies Index ETN
06/17/20245:30PMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:TENKUTenX Keane Acquisition
06/17/20245:30PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:HDHome Depot Inc
06/17/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/17/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/17/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/17/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/17/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/17/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/17/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/17/20245:30PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:ALLYAlly Financial Inc
06/17/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/17/20245:30PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/17/20245:30PMGlobeNewswire Inc.CLM Announces 2024 AGM ResultsTSXV:CLMConsolidated Lithium Metals Inc
06/17/20245:30PMGlobeNewswire Inc.CLM Announces 2024 AGM ResultsZ36
06/17/20245:30PMPR Newswire (US)Pfizer's Setback in Duchenne Muscular Dystrophy Treatment Trial Clears Path for Sarepta, and Many Other Pharma Companies | DelveInsight
06/17/20245:30PMPR Newswire (US)Pfizer's Setback in Duchenne Muscular Dystrophy Treatment Trial Clears Path for Sarepta, and Many Other Pharma Companies | DelveInsight
06/17/20245:30PMPR Newswire (Canada)Le comité exécutif recommande la nomination de Philippe Bourke pour un mandat de quatre ans à titre de président de l'Office de consultation publique de Montréal
06/17/20245:29PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BNSBank Nova Scotia Halifax
06/17/20245:29PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]AMEX:NEWPNew Pacific Metals Corporation
06/17/20245:29PMGlobeNewswire Inc.Lionheart Holdings Announces the Pricing of $200,000,000 Initial Public Offering
06/17/20245:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/17/20245:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OSGOverseas Shipholding Group Inc
06/17/20245:29PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:WTIW and T Offshore Inc
06/17/20245:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMAPUSportsMap Tech Acquisition Corporation
06/17/20245:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PLPlanet Labs PBC
06/17/20245:29PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:PRMWPrimo Water Corporation
06/17/20245:29PMBusiness WireU.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in AdultsNYSE:MRKMerck and Co Inc

Your Recent History

Delayed Upgrade Clock